GlassScriptPhysician profile
Michael Duane Williams
NPI 1477939304
$2,976.57
in general payments reported to CMS, 2019-2025
12 companies · $1,234 in 2025
The $1,234 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $19.42 · 2021: $116 · 2022: $80.53 · 2023: $348 · 2024: $956 · 2025: $1,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,538.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,633.64 | 2019-2025 | Apretude, Cabenuva, Dovato |
| Gilead Sciences, INC. | $500.89 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $356.68 | 2019-2025 | Pifeltro |
| Theratechnologies INC. | $184.83 | 2024-2025 | Egrifta, Trogarzo |
| Astrazeneca Pharmaceuticals LP | $116.35 | 2021 | |
| Astellas Pharma US INC | $55.36 | 2019 | |
| Insmed, INC. | $35.50 | 2019 | |
| Emd Serono, INC. | $25.15 | 2022 | |
| Vyera Pharmaceuticals, LLC | $18.46 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $17.78 | 2019 | |
| Melinta Therapeutics, LLC | $17.59 | 2019 | |
| Abiomed | $14.34 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.